Thumbay Lab for AI revolutionises healthcare education
This cutting-edge facility is designed to support and enhance existing AI programmes at GMU, providing a dynamic learning and research hub for students, faculty, and healthcare professionals. It offers access to advanced tools and technologies that enable learners to explore real-world AI applications across diagnostics, healthcare operations, medical decision-making, and patient care. The lab is a key infrastructure addition under the Thumbay College of Management and AI in healthcare and complements a suite of academic programmes, including master in AI and health informatics, certificate course in AI in Healthcare and certificate course in Generative AI in healthcare.
Speaking at the occasion, Dr Thumbay Moideen stated: 'This lab reflects our commitment to integrating artificial intelligence into every aspect of medical education and healthcare delivery. It will serve as a catalyst for innovation, supporting students and researchers as they develop solutions that shape the future of healthcare.'
Prof. Manda Venkatramana, acting chancellor of Gulf Medical University and vice chancellor – academics, added: 'This lab will significantly enrich the academic experience of our students by giving them hands-on exposure to emerging technologies. It also opens new avenues for collaborative research, innovation, and real-world problem solving in healthcare.'
As part of its strategic ecosystem, the Thumbay College of Management and AI in Healthcare is proud to collaborate with over 15 leading industry partners, including health-tech innovators, AI solution providers, and academic collaborators who contribute to real-time learning and industry-relevant project development.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
2 hours ago
- Khaleej Times
PureHealth reports Dh13.6 billion in revenue and Dh1.03 billion in net profit for H1
PureHealth Holding, the largest healthcare group in the Middle East, on Thursday announced a 9 per cent year-on-year revenue increase to Dh13.6 billion in H1 2025, driven by broad-based growth across both its healthcare and insurance verticals. Ebitda rose 8 per cent year-on-year to Dh2.3 billion in H1-2025, while net profit reached Dh1.03 billion, up 2 per cent year-on-year. As part of its continued evolution and transformation of acquired assets, PureHealth is streamlining its operating model built around two core verticals: Care and Cover. This structure brings together all Group businesses under each vertical, with 'Care' encompassing Hospitals, Procurement, Diagnostics, and Technology, while 'Cover' includes the Group's Insurance operations. Kamal Al Maazmi, Chairman of PureHealth, said: 'PureHealth's strong performance in the first half of 2025 reflects the profound ambition driving our transformation, building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human. By aligning innovation with national priorities and international partnerships, we are not only expanding access to care, but we are also reshaping how health is delivered, experienced, and sustained.' Shaista Asif, Group Chief Executive Officer at PureHealth, commented, 'We delivered solid growth in the first half of 2025 across both our Care and Cover verticals. Our entry into the Property & Casualty segment through Daman strengthens our ability to offer comprehensive, multi-line coverage. We continue to enhance our services through AI-powered solutions that make healthcare more intelligent and efficient. As we expand globally, our focus remains on synergies, transformation of the assets, and delivering better health outcomes within communities we operate.' The Care vertical was the largest contributor to revenue during the period, accounting for 72 per cent of the group's top-line at dh9.8 Billion in revenue, up 7 per cent year-on-year in h1 2025. This growth witnessed across several segments, including hospitals, diagnostics, and technology. Performance in UAE and UK was driven by a 13 per cent increase in outpatient volumes to 4.4 million visits, and a 7 per cent rise in inpatient volumes to 108,000 visits across the Hospitals vertical. In the UAE, this growth was supported by expanded service offerings, increased specialist capacity, and growing demand across SEHA and SSMC networks. In the UK, Circle Health saw increased patient volumes and further strengthened its position through the successful bolt on acquisition of Fairfield Independent Hospital in the Merseyside. The acquisition will expand inpatient capacity and available medical staff, which will ultimately support Circle Health's continued growth in high-demand regions. While Procurement revenue decreased 5 per cent year-on-year to Dh2.6 billion in H1 2025, Rafed has continued expansion of its supplier network. Its recent appointed role as the exclusive distributor for the Abu Dhabi government's Unified Purchasing Programme, has since strengthened its position as a central enabler within the Group's healthcare delivery model. PureLab recorded a 19 per cent year-on-year increase in total testing volume, reaching 16.9 million tests. This strong performance was largely fuelled by enhanced contributions from SEHA and the successful integration of the SSMC laboratory into the PureLab network. The Technology Services reported exceptional growth, with revenue increasing 170 per cent year-on-year to Dh367 million in H1-2025. This was driven by the continued expansion of PureCS, which deployed digital infrastructure and clinical technology solutions across the Group's entities. The Pura app surpassed 620,000 users during the period, while the Group's broader technology backbone is enabling predictive analytics, digital patient engagement, and AI-enhanced care delivery. The Cover vertical revenue increased 14 per cent year-on-year to Dh3.8 billion, supported by an 8 per cent rise in Gross Written Premiums (GWP) to Dh4.9 billion in H1-2025. Growth was further fuelled by new business, driven by expansion into underpenetrated segments and geographies. Membership increased 6 per cent year-on-year, reflecting the Group's compelling value proposition and strong customer retention. PureHealth's balance sheet remains strong, with a Net Debt to Ebitda ratio of 1.4x, providing the Group with ample flexibility to pursue future M&A opportunities and invest in strategic organic growth initiatives across its global healthcare platform. PureHealth repaid Dh1.85 billion in bank debt ahead of its 2027 maturity and currently has no bank debt.
Khaleej Times
2 hours ago
- Khaleej Times
Response Plus Holding reports Dh248 million revenue in H1
Response Plus Holding PJSC, the largest pre-hospital care and emergency medical services provider in the UAE and KSA, has achieved revenue of Dh248.06 million in the first six months of 2025, a growth of 18% compared to Dh209.88 million recorded in the same period last year. Announcing the company's interim financial results for the first half of 2025, RPM registered net profit of Dh20.32 million, while total assets touched Dh404.32 million, up from Dh387.44 million as of December 31, 2024, reflecting continued balance sheet strength and sustained investment momentum. The Earnings Per Share (EPS) for the period was Dh0.10. As part of its commitment to deliver shareholder value, the Board of Directors has approved an interim cash dividend distribution of Dh18 million to the shareholders. Dr Rohil Raghavan, Chief Executive Officer of Response Plus Holding, said: 'The first half of 2025 reflects our strategic agility and continued investment in excellence. From expanding into new geographies to launching the first-of-its-kind services in the region, we are driving impactful growth while prioritizing operational efficiencies. With a strong foundation and forward-looking initiatives, we are well-positioned to deliver greater value to our clients, partners, and shareholders.' RPM delivered strategic milestones during the first half of 2025, reinforcing its leadership in regional and global emergency medical care. The company expanded its aviation emergency operations to The Bahamas, demonstrating its capabilities to scale internationally while enhancing its disaster and air evacuation readiness. During the Hajj season, the company deployed 350 medical professionals and 125 ambulances in 18 clinics across nine stations of Saudi Arabia Railways to support millions of pilgrims visiting the Holy sites. RPM also signed a MoU with Falcon Aviation to operate the UAE's first air ambulance service, a landmark step in enhancing the country's emergency response infrastructure. RPM currently operates over 420 medical sites through key subsidiaries including Prometheus Medical, Occumed Clinic, Health Tech Training Centre, and Medical Manpower Supply. With operations spanning the UAE, KSA, Oman, India, the UK, Switzerland, and Norway, RPM remains firmly committed to redefining the future of pre-hospital emergency medical services.
Zawya
9 hours ago
- Zawya
African startups take on medicine access gaps with smarter supply chains
A healthcare-focused panel discussion at this year's Sapics Conference in Cape Town spotlighted Africa's emergence as a creator of health supply chain innovations with global potential. The session brought together African entrepreneurs who are working to improve access to medicine, patient safety, and supply chain systems. It was moderated by Stella Kivila, Director of Healthtech Strategy & Impact at Salient Advisory, a firm tracking over 1,000 healthtech start-ups across Africa. 'We are seeing a new generation of African entrepreneurs tackling one of the continent's most pressing problems: fragmented and inefficient medicine supply chains,' said Kivila. The cost of fragmentation Public healthcare distribution systems across Africa are often overburdened, with many consumers relying on fragmented private supply chains. According to Kivila, this can add as much as 60% to the final price of medicines. "Patients are left with little guarantee of quality or availability, and there is a significant risk of counterfeit and substandard products entering the system," she said. Two start-ups – Dawa Mkononi from Tanzania and Meditect from Côte d'Ivoire – shared how they are using technology, data and new models to improve healthcare delivery. Dawa Mkononi: "Medicine in the palm of your hand" Dr Joseph Paul, a medical doctor and software engineer, founded Dawa Mkononi after a pivotal experience in a rural Tanzanian village. "While assisting a mother during childbirth, the essential drug needed to accelerate labour was unavailable. Six hours later, the family returned with a medicine that sadly proved ineffective. It was likely a counterfeit." Paul developed a digital platform and distribution system to deliver safe, verified medicines to pharmacies, clinics and hospitals, supported by inventory management and demand forecasting. In urban areas, delivery takes a few hours. The platform also offers credit financing. "Our mission is to make medicine accessible, affordable and safe, through data-driven supply chains," Paul said. The company has reached over 1,000 pharmacies, served more than 500,000 patients, and facilitated over $1m in credit. It is currently growing fourfold annually. Meditect: Restoring trust in medicines For Dr Arnaud Pourredon, founder of Meditect, the turning point also came from a moment in clinical care. 'I couldn't buy malaria treatment for a three-year-old child. That's when I knew we had to fix the system,' he said. Meditect provides digital tools that support drug traceability, supply chain visibility and pharmacy management, with a focus on Francophone Africa. "By improving access to quality medicine and enhancing transparency, we can increase life expectancy in Africa by 10 years," Pourredon said. The platform supports thousands of healthcare professionals and aims to help leapfrog infrastructure gaps using technology. i3: A new model for supporting innovators Both Dawa Mkononi and Meditect are part of the Investing in Innovation (i3) programme, launched in 2022 to connect African health supply chain innovators with donors, governments and the private sector. The initiative has provided $3m in grant funding to 60 start-ups in 18 countries. Rather than acting as a traditional accelerator, i3 offers tailored support and market access, backed by partners including the Gates Foundation, MSD, Cencora, Endless Foundation, HELP Logistics, and Sanofi's Global Health Unit. "Africa doesn't lack ingenuity. It lacks systems to support and scale it," said Kivila. "That's what we're fixing with i3." Locally led systems for Africa and beyond The panel was part of the 47th annual Sapics Conference, attended by more than 700 supply chain professionals from across Africa and the world. As Kivila concluded: "Africa's healthcare future does not have to be imported. It is being built here – by Africans, for Africans, and increasingly, for the world." All rights reserved. © 2022. Provided by SyndiGate Media Inc. (
